Showing results 14 to 33 of 90
< previous
next >
| Issue Date | Title | Author(s) |
| 15-Jun-2023 | Development of a dual energy CT based model to assess response to treatment in patients with high grade serous ovarian cancer: a pilot cohort study | Alizzi, Z; Gogbashian, A; Karteris, E; Hall, M |
| 25-Sep-2022 | Diagnostic Accuracy of Liquid Biomarkers for the Non-Invasive Diagnosis of Endometrial Cancer: A Systematic Review and Meta-Analysis | Karkia, R; Wali, S; Payne, A; Karteris, E; Chatterjee, J |
| 2016 | Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro | Rogers-Broadway, KR; Chudasama, D; Pados, G; Tsolakidis, D; Goumenou, A; Hall, M; Karteris, E |
| 31-Oct-2018 | Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry | Rogers‑Broadway, KR; Kumar, J; Sisu, C; Wander, G; Mazey, E; Jeyaneethi, J; Pados, G; Tsolakidis, D; Klonos, E; Grunt, T; Hall, M; Chatterjee, J; Karteris, E |
| 2010 | Differential expression of mTOR signalling components in drug resistance in ovarian cancer | Foster, H; Coley, HM; Goumenou, A; Pados, G; Harvey, AJ; Karteris, E |
| 11-May-2014 | Differential expression of placental glucocorticoid receptors and growth arrest-specific transcript 5 in term and preterm pregnancies: evidence for involvement of maternal stress. | Mparmpakas, D; Zachariades, E; Sotiriadis, G; Goumenou, A; Harvey, AJ; Gidron, Y; Karteris, E |
| 1-Feb-2022 | Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro | Filipe, A; Chudasama, D; Kerslake, R; Jeyaneethi, J; Anikin, V; Kyrou, I; Randeva, H; Sisu, C; Hall, M; Karteris, E |
| 8-Oct-2022 | Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer | Kerslake, R; Sisu, C; Panfilov, S; Hall, M; Khan, N; Jeyaneethi, J; Randeva, H; Kyrou, I; Karteris, E |
| 2018 | Discovery and development of liquid biomarkers for ovarian and lung cancer | Chudasama, Dimple |
| 27-Apr-2024 | Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro Model | Morea, A; Saravi, S; Sisu, C; Hall, M; Tosi, S; Karteris, E; Storlazzi, CT |
| 22-Feb-2022 | The effect of online and in-person team-based learning (TBL) on undergraduate endocrinology teaching during COVID-19 pandemic | Anas, S; Kyrou, I; Rand-Weaver, M; Karteris, E |
| 27-Dec-2022 | Elevated Circulating Lactate Levels and Widespread Expression of Its Cognate Receptor, Hydroxycarboxylic Acid Receptor 1 (HCAR1), in Ovarian Cancer | Kerslake, R; Panfilov, S; Mustafa, N; Hall, M; Kyrou, I; Randeva, H; Karteris, E; Godfrey, R |
| 2014 | Elucidating the role of DEPTOR in Alzheimer's disease | Davies, J; Zachariades, E; Rogers-Broadway, K-R; Karteris, E |
| 12-Oct-2020 | Endometrial changes in estrogen and progesterone receptor expression during implantation in an oocyte donation program | Klonos, E; Katopodis, P; Karteris, E; Papanikolaou, E; Tarlatzis, B; Pados, G |
| 2019 | Engineered human mesenchymal stem cells for neuroblastoma therapeutics | Karteris, E; Nieddu, V; Piredda, R; Bexel, D; Barton, J; Anderson, J; Sebire, N; Kolluri, K; Janes, SM; Sala, A |
| 11-Jun-2021 | Erratum: On the role of artificial intelligence in medical imaging of COVID-19 (Patterns (2021) 2(6), (S2666389921000957), (10.1016/j.patter.2021.100269)) | Beymer, D; Rajan, D; Coy, A; Mukherjee, VV; Manica, M; Prasanna, P; Ballah, D; Guindy, M; Shaham, D; Shah, PL; Karteris, E; Robertus, JL; Gabrani, M; Rosen-Zvi, M |
| 2021 | Exploration and validation of novel liquid biomarkers in ovarian cancer of diagnostic and prognostic value | Kumar, Juhi |
| 2023 | Exploring novel strategies for assessing response to treatment in patients with advanced ovarian cancer, in particular the role and potential of non-haemopoetic circulating cells and DECT imaging | Alizzi, Zena |
| 2011 | Expression of membrane and nuclear progesterone receptors in two human placental choriocarcinoma cell lines (JEG-3 and BeWo): Effects of syncytialization | Zachariades, E; Foster, H; Goumenou, A; Thomas, P; Rand-Weaver, M; Karteris, E |
| 2010 | Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell lines | Mparmpakas, D; Zachariades, E; Foster, H; Kara, A; Harvey, AJ; Goumenou, A; Karteris, E |
